Free Trial

GeoVax Labs (GOVX) Competitors

GeoVax Labs logo
$1.37 -0.03 (-2.14%)
As of 04:00 PM Eastern

GOVX vs. STTK, CRVO, ONCY, ME, XFOR, IPSC, VNRX, HOWL, IMRX, and AADI

Should you be buying GeoVax Labs stock or one of its competitors? The main competitors of GeoVax Labs include Shattuck Labs (STTK), CervoMed (CRVO), Oncolytics Biotech (ONCY), 23andMe (ME), X4 Pharmaceuticals (XFOR), Century Therapeutics (IPSC), VolitionRx (VNRX), Werewolf Therapeutics (HOWL), Immuneering (IMRX), and Aadi Bioscience (AADI). These companies are all part of the "pharmaceutical products" industry.

GeoVax Labs vs.

Shattuck Labs (NASDAQ:STTK) and GeoVax Labs (NASDAQ:GOVX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Shattuck Labs currently has a consensus target price of $7.50, suggesting a potential upside of 530.25%. GeoVax Labs has a consensus target price of $14.20, suggesting a potential upside of 936.50%. Given GeoVax Labs' stronger consensus rating and higher possible upside, analysts clearly believe GeoVax Labs is more favorable than Shattuck Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shattuck Labs
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.71
GeoVax Labs
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
3.29

Shattuck Labs received 14 more outperform votes than GeoVax Labs when rated by MarketBeat users. However, 96.15% of users gave GeoVax Labs an outperform vote while only 72.22% of users gave Shattuck Labs an outperform vote.

CompanyUnderperformOutperform
Shattuck LabsOutperform Votes
39
72.22%
Underperform Votes
15
27.78%
GeoVax LabsOutperform Votes
25
96.15%
Underperform Votes
1
3.85%

58.7% of Shattuck Labs shares are held by institutional investors. Comparatively, 6.1% of GeoVax Labs shares are held by institutional investors. 10.5% of Shattuck Labs shares are held by insiders. Comparatively, 5.7% of GeoVax Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Shattuck Labs has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500. Comparatively, GeoVax Labs has a beta of 3.06, indicating that its stock price is 206% more volatile than the S&P 500.

GeoVax Labs has lower revenue, but higher earnings than Shattuck Labs.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shattuck Labs$6.44M8.83-$87.30M-$1.53-0.78
GeoVax Labs$3.09M4.18-$25.97MN/AN/A

In the previous week, Shattuck Labs had 7 more articles in the media than GeoVax Labs. MarketBeat recorded 11 mentions for Shattuck Labs and 4 mentions for GeoVax Labs. Shattuck Labs' average media sentiment score of 0.71 beat GeoVax Labs' score of 0.00 indicating that Shattuck Labs is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Shattuck Labs
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GeoVax Labs
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

GeoVax Labs has a net margin of 0.00% compared to Shattuck Labs' net margin of -1,156.46%. Shattuck Labs' return on equity of -61.92% beat GeoVax Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Shattuck Labs-1,156.46% -61.92% -54.49%
GeoVax Labs N/A -809.87%-349.34%

Summary

Shattuck Labs beats GeoVax Labs on 9 of the 16 factors compared between the two stocks.

Remove Ads
Get GeoVax Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GOVX vs. The Competition

MetricGeoVax LabsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$12.93M$6.99B$5.68B$8.32B
Dividend YieldN/A2.72%4.55%4.02%
P/E RatioN/A7.2324.5519.25
Price / Sales4.18230.77395.7294.09
Price / CashN/A65.6738.1634.64
Price / Book0.426.617.064.46
Net Income-$25.97M$142.13M$3.19B$247.07M
7 Day Performance-3.52%2.79%1.49%3.05%
1 Month Performance-6.80%2.70%5.87%-2.85%
1 Year Performance-27.89%-4.42%14.94%4.63%

GeoVax Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GOVX
GeoVax Labs
2.5145 of 5 stars
$1.37
-2.1%
$14.20
+936.5%
-28.9%$12.93M$3.09M0.0010Upcoming Earnings
News Coverage
STTK
Shattuck Labs
3.1652 of 5 stars
$1.17
-1.7%
$7.50
+541.0%
-86.9%$55.86M$6.44M-0.76100Upcoming Earnings
CRVO
CervoMed
3.7012 of 5 stars
$9.05
+40.5%
$25.75
+184.5%
-51.1%$55.84M$7.14M0.004Gap Down
High Trading Volume
ONCY
Oncolytics Biotech
1.4156 of 5 stars
$0.63
+0.5%
$4.00
+536.9%
-37.1%$53.70MN/A-2.3330
ME
23andMe
1.1592 of 5 stars
$2.00
+4.2%
$9.40
+370.0%
-90.9%$53.65M$208.78M-0.13770Analyst Forecast
Options Volume
News Coverage
XFOR
X4 Pharmaceuticals
4.614 of 5 stars
$0.31
-7.8%
$3.50
+1,015.7%
-79.8%$53.50M$1.12M-3.4980Earnings Report
News Coverage
Gap Down
IPSC
Century Therapeutics
1.9903 of 5 stars
$0.62
+4.5%
$6.50
+943.3%
-86.8%$52.97M$2.68M-0.34170Earnings Report
Analyst Forecast
Analyst Revision
VNRX
VolitionRx
1.3174 of 5 stars
$0.57
+1.6%
$3.75
+557.8%
-25.2%$52.83M$1.29M-1.5880
HOWL
Werewolf Therapeutics
1.9966 of 5 stars
$1.17
-2.9%
$9.00
+672.5%
-81.6%$52.22M$1.89M-0.7640
IMRX
Immuneering
3.1135 of 5 stars
$1.68
+4.7%
$11.00
+556.7%
-31.8%$52.01M$320,000.00-0.8560Earnings Report
Analyst Forecast
AADI
Aadi Bioscience
0.8699 of 5 stars
$2.10
+6.1%
$1.67
-20.6%
-6.0%$51.86M$25.07M-0.9240Earnings Report
Remove Ads

Related Companies and Tools


This page (NASDAQ:GOVX) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners